blue cross blue shield glp-1 coverage 2026 Drugs Could Raise Employer Health Premiums IBX members face GLP-1 drug

Potential for Other Conditions Beyond EPP, researchers have explored the use of afamelanotide and other melanocortin agonists for conditions such as vitiligo, a disorder characterised by loss of skin pigmentation, and polymorphous light eruption (PLE), a form of sun allergy

Options can include azelaic acid, vitamin C, retinoids, tranexamic acid, or combination therapies

Reduced sexual distress: patients reported lower scores on the Female Sexual Distress Scale

[21] Onakpoya I, Hung SK, Perry R, et al

Therefore, more studies are needed to explore its effects

Semaglutide (used in GLP-1 medications like Ozempic and Wegovy) is a peptide drug, and tesamorelin is an FDA-approved synthetic growth hormone-releasing factor analogue